BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1434831)

  • 1. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ
    Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
    Degos L
    Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
    [No Abstract]   [Full Text] [Related]  

  • 7. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

  • 8. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 9. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
    Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor.
    Higuchi T; Kizaki M; Omine M
    Leuk Res; 2004 May; 28(5):525-32. PubMed ID: 15068906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proposals for the objective indices for evaluating the differentiation of leukemic cells by all-trans retinoic acid in the patients with acute promyelocytic leukemia].
    Nakajima H; Kizaki M; Takayama N; Kawai Y; Watanabe K; Okamoto S; Ikeda Y
    Rinsho Ketsueki; 1996 Mar; 37(3):208-13. PubMed ID: 8727344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation therapy of leukemia.
    Degos L
    Leuk Lymphoma; 1994; 13 Suppl 1():39-43. PubMed ID: 8075578
    [No Abstract]   [Full Text] [Related]  

  • 13. [All-trans retinoic acid (Tretinoin)].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):741-6. PubMed ID: 9126315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring all-trans-retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by Fourier-transform infrared spectroscopy.
    Liu MJ; Wang Z; Wu RC; Sun SQ; Wu QY
    Leukemia; 2003 Aug; 17(8):1670-4. PubMed ID: 12886260
    [No Abstract]   [Full Text] [Related]  

  • 15. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maturation of differentiation therapy.
    Cheson BD
    N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C in the promyelocytic leukemia cell differentiation of granulocytes.
    Wu XZ; Shao GY; Chen SR; Huang ME; Wang ZY
    Chin Med J (Engl); 1991 Jan; 104(1):32-5. PubMed ID: 1879193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L
    Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.